Gene therapy therapeutics development and manufacturing has a goal to treat disease by targeting the cause of the disease. Interest in gene therapy has continued to increase and the industry is evolving, but the design, development and scaling of manufacturing processes is complex and challenging.
In a panel discussion, co-sponsored by 3M, two industry experts discuss the strategies and opportunities for building next-generation gene therapy processes and new gene therapy manufacturing facilities. Learn more about the different approaches, in process development and manufacturing adopted along with the challenges, risks, and benefits.
Arsalan Arif is a news media entrepreneur who set out in 2015 to build his vision of an independent biotech news company at Endpoints News.